EUVIMEDEUVIMED entdecken
Crossref

Unraveling immune heterogeneity across pan-cancer and deep insights in lung adenocarcinoma based on alternative splicing

Yuquan Wang, Erliang Guo, Min Zou, Chen Lv, Yanrui Cui, Songmei Zhai, Shaocong Sang, Kai Xiong, Xiuqi Yang, Shuping Zhuang, Yunyan Gu iD, Haihai Liang

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiae104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Yuquan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State Key Laboratorary-Province Key Laboratories o…. Hauptthemen laut MEDLINE: Alternative Splicing, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Fund Project of Heilongjiang Province, Scientific Research Project of Provincial Scientific Research Institutes of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alternative splicing (AS) participates in tumor development and tumor microenvironment formation. However, the landscape of immune-infiltrating AS events in pan-cancer and mechanisms of AS in lung adenocarcinoma (LUAD) have not been comprehensively characterized. We systematically profiled the immune-infiltrating AS event landscape of pan-cancer using data from The Cancer Genome Atlas, analyzing both commonalities and specific characteristics among different cancer types. We found that AS events tend to occur specifically in one cancer type rather than in multiple cancer types. AS events were used to classify 512 LUAD samples into 2 subtypes by unsupervised clustering: the aberrant splicing subtype and the immune-infiltrating subtype. The 2 subtypes showed significant differences in clinicopathology, prognosis, transcriptomics, genomics, and immune microenvironment. We constructed a classification signature comprising 10 genes involved in 14 AS events using logistic regression. The robustness of the signature was validated in 3 independent datasets using survival analysis. To explore AS mechanisms in LUAD, we constructed subtype-specific coexpression networks using Pearson correlation analysis. AS event of AKT3 regulated by splicing factor ENOX1 was associated with poor prognosis in LUAD. Overall, we outline AS events associated with immune infiltration in pan-cancer, and this study provides insights into AS mechanisms in LUAD patient classification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingAdenocarcinoma of LungLung NeoplasmsHumansTumor MicroenvironmentPrognosisGene Expression Regulation, NeoplasticBiomarkers, TumorTranscriptomeGene Expression Profiling

Stichwörter der Autor:innen

alternative splicingimmune infiltrationlung adenocarcinomapan-cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State Key Laboratorary-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular…
  • Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, 150081, China.
  • Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, No. 157 Baojian Road, NanGang District, Harbin, Heilongjiang Province, 150081, China.

ORCID-Profile: Yunyan Gu

Förderung

  • National Natural Science Foundation of China
  • Scientific Fund Project of Heilongjiang Province
  • Scientific Research Project of Provincial Scientific Research Institutes of Heilongjiang Province

Zitieren

APA

Wang, Y., Guo, E., Zou, M., Lv, C., Cui, Y., Zhai, S., Sang, S., Xiong, K., Yang, X., Zhuang, S., Gu, Y., & Liang, H. (2025). Unraveling immune heterogeneity across pan-cancer and deep insights in lung adenocarcinoma based on alternative splicing. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae104

Vancouver

Wang Y, Guo E, Zou M, Lv C, Cui Y, Zhai S, et al. Unraveling immune heterogeneity across pan-cancer and deep insights in lung adenocarcinoma based on alternative splicing. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae104

BibTeX
@article{Wang2025,
  author = {Wang, Yuquan and Guo, Erliang and Zou, Min and Lv, Chen and Cui, Yanrui and Zhai, Songmei and Sang, Shaocong and Xiong, Kai and Yang, Xiuqi and Zhuang, Shuping and Gu, Yunyan and Liang, Haihai},
  title = {Unraveling immune heterogeneity across pan-cancer and deep insights in lung adenocarcinoma based on alternative splicing},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiae104}
}
Kostenlos starten →